Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

This Drug Helps Investors Rest Easy
Motley Fool
Sunday, December 2, 2012 - 12:02pm
tags:
suvorexant, Merck, insomnia, hypnotics, Sanofi, Ambien
Wall Street Loves Galena Biopharma. Should You?
Motley Fool
Sunday, December 2, 2012 - 11:55am
tags:
Galena Biopharma
3 Top Biopharma Stocks of 2012
Motley Fool
Sunday, December 2, 2012 - 11:54am
tags:
Arena Pharmaceuticals, Celsion, Sarepta Therapeutics
Industry calls for reform of lagging drug review system (in China)
Global Times, China
Sunday, December 2, 2012 - 11:53am
tags:
China
1 Deal Arena Investors Might Have Missed
Motley Fool
Sunday, December 2, 2012 - 11:52am
tags:
Arena Pharmaceuticals, Belviq, weight loss, obesity
Are Short-Sellers Onto Something at Pluristem Therapeutics?
Motley Fool
Sunday, December 2, 2012 - 11:49am
tags:
Pluristem Therapeutics
Generic drug maker Teva plans to reshape
Irish Times, Ireland
Sunday, December 2, 2012 - 11:48am
tags:
Teva
This BioPharma Stock is Making All The Right Moves
Motley Fool
Sunday, December 2, 2012 - 11:47am
tags:
Arena Pharmaceuticals
One Person's Trash Is Another Person's Treasure Selection: Dendreon
Motley Fool
Sunday, December 2, 2012 - 11:46am
tags:
Dendreon
Mylan Inc arm gets US OK for Tolterodine tartrate tablets
Healthcare Global
Saturday, December 1, 2012 - 10:58am
tags:
Mylan, generics, Detrol, overactive bladder
Cumberland Pharmaceuticals lays off one-third of salesforce
bizjournals
Saturday, December 1, 2012 - 10:56am
tags:
Cumberland
Sucampo Announces Approval for Updates to AMITIZA; Endo Health Solutions Stock Halted Following News
Equities.com
Saturday, December 1, 2012 - 10:52am
tags:
Sucampo, Amitiza, Endo Health Solutions, irritable bowel syndrome
Supreme Court to review lawsuits over flaws in generic drugs
Yahoo/Reuters
Saturday, December 1, 2012 - 10:50am
tags:
generics, lawsuits
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, December 1, 2012 - 10:48am
tags:
Acura Pharmaceuticals, Sucampo, Lannett, Pfizer
RTP drug firm BioCryst calls off merger with private company
WRALtechwire
Saturday, December 1, 2012 - 10:46am
tags:
Biocryst, Presidio Pharmaceuticals, M&A
Supernus' Shocking Dilution
Motley Fool
Saturday, December 1, 2012 - 9:55am
tags:
Supernus Pharmaceuticals
Amarin's Big Initiation
Motley Fool
Saturday, December 1, 2012 - 9:54am
tags:
Amarin
A Winning Long-Term Growth Pick
Motley Fool
Saturday, December 1, 2012 - 9:53am
tags:
JNJ
Drugmaker Ranbaxy halts generic Lipitor production
Yahoo/AP
Saturday, December 1, 2012 - 9:52am
tags:
Ranbaxy, Lipitor, generics
Endo Health Sues FDA Over Safety of Painkiller Opana
Bloomberg
Saturday, December 1, 2012 - 9:36am
tags:
Endo, Opana, pain management

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.